STRO - Balance Sheet - Sutro Biopharma, Inc.

Current Liabilities	132 M
Accounts Payable	10.5 M
Short-Term Debt	7.48 M
Other Current Liabilities	114 M
Non-Current Liabilities	211 M
Long-Term Debt	0
Other Non-Current Liabilities	211 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	190.3	69.3	47.3	30.4	206.2	5.0	125.3	22.0	11.6
Short Term Investments	126.6	306.4	287.1	167.5	162.0	112.9	79.2	0	35.9
Receivables	8.6	36.1	7.1	12.5	5.6	6.3	2.5	1.6	0.6
Inventory	0	0	(11.7)	1	0	0	1	0	0
Other Current Assets	17.8	9.8	11.7	8.1	4.5	8.8	5.9	2.0	1.6
Total Current Assets	343.3	421.5	309.5	218.5	378.2	128.6	209.9	25.6	49.7
PP&E	35.9	44.8	51.1	51.6	12.9	9.6	10.9	14.0	18.7
Intangible Assets	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	32.0	68.8	0.9	15.6	15 K	0.2	0.5
Other Long Term Assets	8.0	4.4	14.4	2.5	2.1	2.6	2.2	0.9	0.4
Other Assets	0	0	0	0	0	0	0	0	0
Total Assets	387.2	470.7	406.9	341.4	394.1	156.4	223.1	40.8	69.3
LIABILITIES
Accounts Payable	10.5	9.4	4.8	6.0	5.5	5.6	3.1	2.9	3.4
Short Term Debt	7.5	10.5	21.7	11.4	0	1.0	4.7	14.6	0
Other Current Liabilities	44.1	38.0	23.3	18.8	9.4	6.9	7.1	3.8	3.2
Total Current Liabilities	131.9	93.7	139.5	41.7	29.6	33.0	36.4	32.0	50.2
Long Term Debt	0	23.2	33.3	47.0	24.5	8.9	10.0	0	0
Deferred Tax Income	0	0	0	0	1.3	0.4	0.5	0	(1.2)
Other Liabilities	198.2	1.7	0.1	0.1	1.8	0.5	0.6	104.7	104.1
Total Liabilities	342.6	321.1	189.9	88.8	62.1	58.6	91.6	149.8	160.2
EQUITY
Common Stock	83 K	61 K	58 K	46 K	46 K	23 K	23 K	0	16 K
Retained Earnings	(786.9)	(559.4)	(452.6)	(333.4)	(227.9)	(195.7)	(150.3)	(115.0)	(95.3)
Other Accumulative Comprehensive Income/Loss	39 K	21 K	(0.6)	(0.3)	0.1	0.2	47 K	(0.2)	17 K
Total Equity	44.6	149.6	217.0	252.6	332.0	97.8	131.5	(109.0)	(90.9)
Total Liabilities and Equity	387.2	470.7	406.9	341.4	394.1	156.4	223.1	40.8	69.3
SHARES OUTSTANDING
Common Shares Outstanding	76.8	60.2	50.7	46.1	32.6	23.0	5.8	7.0	7.0

Free